Inhibition of TGF-β Enhances the In Vivo Antitumor Efficacy of EGF Receptor–Targeted Therapy

EGF receptor (EGFR)–targeted monoclonal antibodies (mAb), such as cetuximab, execute their antitumor effect in vivo via blockade of receptor–ligand interactions and engagement of Fcγ receptors on immune effector cells that trigger antibody-dependent cell-mediated cytotoxicity (ADCC). We show that tu...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Bedi, Atul, Chang, Xiaofei, Noonan, Kimberly, Pham, Vui, Bedi, Rishi, Fertig, Elana J., Considine, Michael, Califano, Joseph A., Borrello, Ivan, Chung, Christine H., Sidransky, David, Ravi, Rajani
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2012
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3640459/
https://ncbi.nlm.nih.gov/pubmed/22927667
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-12-0101-T
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items